首届阿斯利康中国肿瘤患者之声交流会举办,并宣布成立阿斯利康中国肿瘤诊疗变革患者顾问委员会,共同推动科学创新、药物可及与全病程管理 上海2026年9月21日 /美通社/ -- 阿斯利康中国首届肿瘤患者之声交流会(Patient Advocacy Leaders Summit,PALS)在上海举行。近40位患者组织及倡导者代表、临床专家、科研学者、卫生经济专家与产业伙伴等多方代表,以及阿斯利康全球与...
Source Link首届阿斯利康中国肿瘤患者之声交流会举办,并宣布成立阿斯利康中国肿瘤诊疗变革患者顾问委员会,共同推动科学创新、药物可及与全病程管理 上海2026年9月21日 /美通社/ -- 阿斯利康中国首届肿瘤患者之声交流会(Patient Advocacy Leaders Summit,PALS)在上海举行。近40位患者组织及倡导者代表、临床专家、科研学者、卫生经济专家与产业伙伴等多方代表,以及阿斯利康全球与...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.